Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

2H24: Minimal surprises

Atlas Arteria
3:27pm
February 27, 2025
Toll revenue had already been released, so a key forecast risk was already known. Asset EBITDA was broadly as expected. ALX’s updated DPS guidance and policy supports our 40 cps DPS forecast over coming years. Implied cash yield at current prices is 7.7%, albeit DPS growth may be limited. Forecast changes are minimal, except for updating for the revised FE debt amortisation profile. BAU valuation/target price decrease 2 cps to $4.31/$4.60.

Picks up a bargain?

Karoon Energy
3:27pm
February 27, 2025
A strong set of CY24 numbers, helped by a material cash tax saving, KAR also announced it had struck a deal buying Bauna’s FPSO for a good-looking price. KAR estimates the ~US$115m acquisition has IRR of >20% and ~4 year payback. Management is focused on its existing portfolio, with no M&A plans. Bumper A9.496 cent dividend (6.5% yield), and US$85.7m share buyback. Maintain ADD rating with an upgraded A$2.45 target price (was A$2.20).

Cruising past the industry margin pressures

Eagers Automotive
3:27pm
February 27, 2025
APE delivered FY24 PBT of A$371m (-14% on pcp), a strong outcome in the context of broad industry pressures and severely weak peer results. ROS margin was held stable in 2H24 at ~3.3% (vs industry average ~1.2%). APE pointed to stable to improving near-term margin, with uplift expected medium-term. APE guided to ~A$1bn top-line growth (A$1.3bn delivered FY24), underpinned by completed acquisitions and organic growth in EA123 and the Retail JV. Near-term, visible top-line growth and a persistent focus on margin provides earnings resilience and a solid growth outlook. Long-term, we expect APE to continue to prove that the groups scale extends its competitive advantage, and along with industry change increases the growth avenues. Add maintained.

Industrial Access was the star performer

Acrow
3:27pm
February 27, 2025
ACF’s 1H25 result was in line with our expectations and management’s guidance provided in November. The result was driven by strong growth in Industrial Access, partly offset by lower contributions from Formwork and Commercial Scaffold. Management has maintained FY25 revenue and EBITDA guidance in addition to providing underlying NPAT and underlying EPS targets. We make no changes to FY25F EBITDA but lift FY26F and FY27F EBITDA marginally (by 1-2%). Our target price rises slightly to $1.32 (from $1.30). In our view, ACF’s increasingly diversified business that includes screens, jumpform, industrial access and formwork in addition to ongoing new product development provides multiple growth levers in an operating environment that remains healthy. Trading on 8.6x FY26F PE and 5.7% yield, we believe the long-term investment proposition remains attractive and maintain our Add rating.

Cash machine

Qantas Airways
3:27pm
February 27, 2025
QAN reported an in line 1H25 result with Jetstar’s strong growth, better than expected FCF and a large fully franked dividend (first since COVID) the highlights. Whilst QAN’s operating environment remains favourable, we continue to see the stock fully valued at current levels. HOLD maintained.

A nice 2Q25 turn around

Clearview Wealth
3:27pm
February 27, 2025
Overall we saw this result as delivering well after a tough 1Q25. The key highlight being claims normalising in 2Q25, and all key FY26 targets being re-affirmed (with a lift to the gross premium target). We increase our CVW FY25F/FY26F EPS by 2%-16% on higher top-line growth and improved claims assumptions. Our PT increases to A$0.65. On face value, the claims spike CVW saw in 1Q25 looks like a blip rather than a trend. We see significant upside in CVW at current levels and maintain our ADD call.

Back on the throttle

Motorcycle Holdings
3:27pm
February 27, 2025
MTO continued its recent momentum through to the end of 1H25, delivering an improved result, with sales +12%; EBITDA +20%; and NPAT up 43%. The result was ~4% ahead of our sales and ~7% ahead of our NPAT expectations – a positive start to the year after a challenging FY24. Strong sales growth within Mojo (+21%) and New/Used MCs (+11%) drove the result, as sales growth accelerated towards the end of the CY24. The group remains cautiously optimistic for another positive 2H25 result, with some momentum carrying into January. We are encouraged by the ongoing recovery of the business and view MTO as well positioned for a turn in the cycle. We continue to view the valuation as undemanding on 8x FY25F PE and an 8% yield. Add.

1H25 and outlook disappoints

Helloworld
3:27pm
February 27, 2025
HLO’s 1H25 result materially missed our forecast and consensus expectations. EBITDA fell 20% on the pcp, despite the 1H25 having an additional month of the acquisitions. The highlight was the large interim dividend given HLO’s strong balance sheet. FY25 EBITDA guidance was also significantly below consensus estimates. Guidance implies a stronger 2H vs 1H and HLO highlighted its solid forward bookings. We have made large downgrades to our forecasts. Despite HLO’s undemanding trading multiples, we maintain a Hold rating until there is a clearer picture on its outlook and earnings growth resumes.

Margin improvement coming

Monash IVF
3:27pm
February 27, 2025
MVF’s 1H25 result was in line with guidance provided, with NPAT up 5.5% to $15.8m. Short term volatility in industry cycle volumes does not alter our view of the strong structural growth drivers that we think will underpin growth in the IVF industry. We expect MVF to continue to gain market share in Australia, leverage infrastructure and patient management system to drive higher margins and continue to expand in South East Asia, which we think will drive growth in earnings over the next few years. We have lowered our NPAT in line with guidance provided. We have decreased our target price to $1.45 (from $1.50) driven by earnings revisions. ADD retained.

1H inline- EU jettison? Only one piece of the puzzle

Ramsay Health Care
3:27pm
February 27, 2025
1H underlying operating profit was pre-released so unsurprisingly in line, driven by low single digit admissions growth and indexation gains. However, earnings were a mixed bag, with growth in Australia and UK acute hospitals, while Elysium and EU went backwards on going inflationary pressures. While it is a welcome sign “strategic options” are actively being pursued for the EU division, with possible divestment in the air, new management flagged a multi-year transformation is required in remaining business and it continues to run a ruler across all divisions, making it difficult at this early stage to assess if adjustments in operational strategy will have the desired impact. We adjust FY25-27 earnings, with our price target decreasing to A$37.10. Hold.

News & Insights

Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more
The U.S. and China, through negotiations led by the Chinese Deputy Premier and U.S. Treasury Secretary Scott Bessent, agreed to a 90-day tariff reduction from over 125% to 30% and 10% respectively

US and Chinese actions had led to an unintended embargo of trade between the world’s two largest economies.

In recent days there has been discussion of the temporary “cease fire” in the tariff war between the US and China.

The situation was that both countries had levied tariffs on each other more than 125%. This had led to a mutual embargo of trade between the two world is two largest economies. Then as a result of negotiation between the Deputy Premier of China and US Treasury Secretary Scott Bessent both China and the US agreed to a 90 day pause in “hostilities” where both sides agreed to reduce the US tariff on the China to 30 percent and the Chinese tariff on the US to 10%.

Some suggested that this meant that “China had won” others suggested that the “US had won.” To us this really suggests that both parties were playing in a different game. The was a game in which both sides had won.

To understand why this is the case we must understand a little of the theory of this type of competition. Economists usually use discuss competition in terms of markets where millions of people are involved. In such a case we find a solution by finding the intersection of supply and demand which model the exchange between vast numbers of people.

But here we are ware talking of a competition where only two parties are involved.

When exceedingly small numbers like this are involved, we find the solution to the competition by what is called “Game Theory.”

In this game there are only two players. One is called China, and the other is called the US. Game theory teaches us that are there three different types of games. The first is a zero-sum game. In this game there two sides are competing over a fixed amount of product. Again, this is called " A zero sum game “. Either one party gets a bigger share of the total sum at stake and the other side gets less. This zero-sum game is how most of the Media views the competition between the US and China.

A second form is a decreasing sum game. An example of this is a war. Some of the total amount that is fought over is destroyed in the process. Usually both sides will wind up worse than when they started.

Then there is a third form. This form is called an ‘increasing sum game.’ This is where both sides cooperate so that the total sum in the game grows because of this cooperation. We think that what happened in the US and China negotiation was an increasing sum game.

As Scott Bessent said at the Saudi Investment Forum in Riyadh soon after the agreement was signed, “both sides came with a clear agenda with shared interests and great mutual respect.”

He said, “after the weekend, we now have a mechanism to avoid escalation like we had before. We both agreed to bring the tariff levels down by 115% which I think is very productive because where we were with 145% and 125% was an unintended embargo. That is not healthy for the two largest economies in the world.”

He went on, “when President Trump began the tariff program, we had a plan, we had a process. What we did not have with the Chinese was a mechanism. The Vice Premier and I now call this the ‘Geneva mechanism’”.

Both sides cooperated to make both sides better off. Bessent added “what we do not want, and both sides agreed, is a generalised decoupling between the two largest economies in the world. What we want is the US to decouple in strategic industries, medicine, semiconductors, other strategic areas. As to other countries; we have had very productive discussions with Japan, South Korea, Indonesia, Taiwan, Thailand. Europe may have collective action problems with the French wanting one thing and the Italians wanting a different thing. but I am confident that with Europe, we will arrive at a satisfactory conclusion.

We have a very good framework. I think we can proceed from here.”

What we think we can see here is that the United States and China have cooperated to both become better off. This is what we call an increasing sum game.

They will continue their negotiation using that approach. This will do much to allay the concerns that so many had about the effect of these new tariffs.

Read more